Blood test developer Inanovate lands $3.1 mln Series C
South Dakota and North Carolina-based Inanovate Inc., a developer of blood tests for cancer and autoimmune diseases, has secured $3.1 million in Series C financing. South Dakota Equity Partners led the round.
4 April 2019•1 min read
